Last update 01 Nov 2024
Recombinant Timothy grass pollen allergoids(Biomay AG)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Allergen extract |
Synonyms High-dose rPhleum, Recombinant Timothy grass pollen allergoids, rPhleum |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Recombinant Timothy grass pollen allergoids(Biomay AG)Randomised double blind placebo controlled pivotal study to evaluate efficacy and safety of rPhleum in adult and adolescent patients suffering from rhinoconjunctivitis +/- controlled Asthma - 2nd pivotal rPhleum
A Double-blind Placebo-controlled Dose-response Study for Evaluation of Safety and Efficacy of Immunotherapy With a Cocktail of Recombinant Major Allergens of Timothy Grass Pollen (Phleum Pratense) Adsorbed to Aluminium Hydroxide in Patients With IgE-mediated Allergic Rhinitis/Rhinoconjunctivitis With or Without Bronchial Asthma
100 Clinical Results associated with Recombinant Timothy grass pollen allergoids(Biomay AG)
Login to view more data
100 Translational Medicine associated with Recombinant Timothy grass pollen allergoids(Biomay AG)
Login to view more data
100 Patents (Medical) associated with Recombinant Timothy grass pollen allergoids(Biomay AG)
Login to view more data
100 Deals associated with Recombinant Timothy grass pollen allergoids(Biomay AG)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anaphylaxis | Phase 3 | IT | - | |
| Anaphylaxis | Phase 3 | DE | - | |
| Anaphylaxis | Phase 3 | GB | - | |
| Rhinitis, Allergic | Phase 3 | - | - | |
| Rhinitis, Allergic | Phase 3 | - | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | PL | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | ES | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | DE | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | FR | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | GB | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 27 | (rnbhlqhpoe) = gacebhqqci lswnttrnml (cqjakusorz ) | - | 16 May 2019 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free